miR-378 was suggested to serve as a potential biomarker for various conditions, including Duchenne muscular dystrophy (DMD), an incurable, genetic disorder caused by the lack of dystrophin–structural protein in muscles. Here, DMD is linked to Duchenne muscular dystrophy.